Latest updates for Rrms

Fresh curated links around RRMS are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Scientists link early relapsing MS to subtle changes in brain white matter
  • Study finds MRI-detected myelin changes tied to disability in RRMS
  • Tiziana inks deal for clinical trial testing its experimental treatment in RRMS

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

multiplesclerosisnewstoday.com /1 month ago

Scientists link early relapsing MS to subtle changes in brain white matter

A trio of European scientists has linked subtle changes in the brain’s white matter — tissue rich in nerve cell projections — to early relapsing-remitting multiple sclerosis (RRMS)...

Read source
multiplesclerosisnewstoday.com /1 month ago

Study finds MRI-detected myelin changes tied to disability in RRMS

A specialized MRI technique detected signs of myelin and iron loss in nerve fibers beneath the brain’s outer layer in people with relapsing-remitting multiple sclerosis (RRMS), but...

Read source
multiplesclerosisnewstoday.com /1 month ago

Tiziana inks deal for clinical trial testing its experimental treatment in RRMS

Tiziana Life Sciences has signed a deal with strategic partners to support a clinical trial designed to test its experimental nasal therapy foralumab in people with hard-to-treat r...

Read source
multiplesclerosisnewstoday.com /1 month ago

Greater disability linked to more severe depression in RRMS study

Among people with relapsing-remitting multiple sclerosis (RRMS), greater physical disability is associated with higher depression severity, according to a small study from Egypt. T...

Read source
multiple-sclerosis-research.org /1 month ago

Time for MSbase

Sound like time for MS base to get involved and sort this out as a matter Patel MA, Punnen TG, Shan KS, McCreary MC, Wright CM, Munoz SB, Hardeman P, Burgess KW, Greenberg BM, Hort...

Read source
multiple-sclerosis-research.org /1 week ago

PIRA should be abbreviated BS.

Progression independent of relapse (PIRA) is the concept that is being spun to define progressive MS. This contrasts to RAW = relapse associated worsening. However I have long said...

Read source
multiple-sclerosis-research.org /1 month ago

Frexalimab for progressive MS?

Here we go…Frexalimab to inhibit progressive MS?. Frexalimab is a CD40Ligand blocking antibody for development in MS. Frexalimab inhibits relapsing and progressive MS, so they say,...

Read source
multiple-sclerosis-research.org /1 day ago

Remibrutinib LATE BREAKING ABSTRACT becomes an Instant Paper

Weindl et al. Remibrutinib versus teriflunomide in relapsing multiple sclerosis (REMODEL-1 and REMODEL-2): two randomised, phase 3 trials Lancet Online firstOctober 23, 2026Open ac...

Read source
multiplesclerosisnewstoday.com /1 month ago

Pain, sleep, stress linked to fatigue severity in relapsing-remitting MS

Among people with relapsing-remitting multiple sclerosis (RRMS) and mild to moderate disability, fatigue severity was associated with a range of physical and psychological factors...

Read source
multiplesclerosisnewstoday.com /1 month ago

Experimental MS drug bests approved therapy in cutting relapses in 2 trials

An experimental oral drug called remibrutinib outperformed the approved therapy Aubagio (teriflunomide) in reducing disease flare rates in two large, late-stage clinical trials inv...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Rrms

multiple-sclerosis-research.org

Recent coverage from public sources
Public source

multiplesclerosisnewstoday.com

Recent coverage from public sources
Public source